Examining the In-Vitro Efficacy of the IAP Antagonist Birinapant as a Single-Agent or in Combination with Dacarbazine to Induce Melanoma Cell Death

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Vesna Vetma, Jan Rožanc, Emilie M Charles, Christian T Hellwig, Leonidas G Alexopoulos, Markus Rehm

Journal title: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Journal publisher: Cognizant Communication Corp.

Published year: 2017

DOI identifier: 10.3727/096504017X14897145996933

ISSN: 0965-0407